Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The NGS-Based RNA-Sequencing Market Valuation Change Between Now And 2029?

The market capacity of ngs-based rna-sequencing has seen a dramatic increase in recent times. There is an anticipated growth from $3.41 billion in 2024 up to $4.2 billion in 2025, subject to a compound annual growth rate (CAGR) of 23.3%. The surges seen in the historic period are due to initiatives in genomic research, cut-downs in sequencing costs, progress in drug discovery and development, personal medicine, and an increase in the adoption of ngs.

There is an anticipated substantial expansion in the ngs-based rna-sequencing market, with an expected increase to $10.26 billion by 2029, marking a compound annual growth rate (CAGR) of 25.0%. This projected growth over the forecast period is largely due to areas such as clinical diagnostics, international collaborations, ethical and regulatory guidelines, agricultural and environmental studies, along with green genomics. Key trends expected to further drive this market growth during the forecast period include single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, the integration of multi-omics, and sustainable farming practices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Underlying Factors Are Supporting The NGS-Based RNA-Sequencing Market Growth?

Advancements in precision medicine are propelling the growth of the NGS-based RNA sequencing market. By allowing physicians to create customized treatment plans informed by a genetic comprehension of a patient’s ailment, precision medicine is undergoing augmentation, particularly for the management of serious disorders such as cancer. The role of NGS-based RNA sequencing becomes crucial as it enables the identification of the fundamental cause of the disease and the prescription of particular precision medicines consequently. For example, a report by the Personalized Medicine Coalition (PMC), a U.S. nonprofit entity, from February 2023 explained that personalized medicines made up 35% of newly accepted NMEs in 2021. With a dozen fresh approvals in 2022, their consistent share has been maintained at a minimum of a quarter of new drug approvals over the previous eight years. This depicts a substantial surge compared to under 10% a decade ago. The implication here is that as the appeal for precision medicines escalates, we can anticipate a concurrent increase in the demand for NGS-based RNA sequencing.

Which Sub-Segments Are Driving Growth Within The NGS-Based RNA-Sequencing Market?

The ngs-based rna-sequencingmarket covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics

4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

What Future-Focused Trends Are Anticipated In The NGS-Based RNA-Sequencing Market?

The prevailing trend in the NGS-based RNA sequencing market involves strategic alliances. Businesses are forming partnerships with firms specializing in NGS-based RNA sequencing to penetrate new markets and utilize each other’s resources in a more effective way. As an example, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services, collaborated with several industrial and academic partners. This collaboration has the goal of enhancing the rapidity of public health emergency responses and creating an innovative diagnostic methodology capable of identifying all known and emerging respiratory RNA viruses with a single test.

Which Companies Hold A Competitive Edge In The 71 Market?

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Region Dominates The NGS-Based RNA-Sequencing Market Today?

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2025, By The Business Research Company

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Antisense And Rnai Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model